Allworth Financial LP grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 1,777.8% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,225 shares of the company’s stock after buying an additional 4,000 shares during the period. Allworth Financial LP’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $240,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the company. Spire Wealth Management lifted its stake in Direxion Daily S&P Biotech Bull 3x Shares by 46.3% during the second quarter. Spire Wealth Management now owns 1,106 shares of the company’s stock worth $63,000 after purchasing an additional 350 shares during the last quarter. McGuire Investment Group LLC increased its stake in Direxion Daily S&P Biotech Bull 3x Shares by 27.4% during the second quarter. McGuire Investment Group LLC now owns 5,028 shares of the company’s stock valued at $286,000 after purchasing an additional 1,080 shares during the last quarter. Ethos Financial Group LLC raised its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.5% during the second quarter. Ethos Financial Group LLC now owns 9,055 shares of the company’s stock worth $515,000 after purchasing an additional 2,270 shares during the period. Finally, XTX Topco Ltd acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the first quarter worth $313,000.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 1.7%
NYSEARCA LABU opened at $135.99 on Tuesday. Direxion Daily S&P Biotech Bull 3x Shares has a one year low of $32.55 and a one year high of $140.86. The company has a 50-day simple moving average of $106.79 and a 200-day simple moving average of $77.11.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Further Reading
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Conference Calls and Individual Investors
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- The 3 Best Fintech Stocks to Buy Now
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
